Navigation Links
ETHICON Launches the Latest Innovation in Hernia Repair Platform; PROCEED(TM) Ventral Patch (PVP(TM) Device)
Date:12/16/2008

New System Capitalizes on Innovative Materials and Technology

SOMERVILLE, N.J., Dec. 16 /PRNewswire/ -- ETHICON, INC, a global medical device company, today announced the launch of the PROCEED Ventral Patch (PVP Device), the latest addition to its family of hernia products. PVP Device is the first and only umbilical hernia repair device featuring lighter-weight mesh and exclusive, absorbable deployment technology. It is indicated for use in umbilical, epigastric, small ventral and trocar site hernias.

Hernias are extremely common. Umbilical hernias occur near the belly button or navel, which has a natural weakness from the blood vessels of the umbilical cord. These hernias may occur in infants at or just after birth, and may resolve at 3 or 4 years of age. However, the area of weakness can persist throughout life and can occur in men, women, and children at any time. In adults, umbilical hernias will not resolve and may progressively worsen over time. They are sometimes caused by abdominal pressure due to being overweight, excessive coughing, or pregnancy.

The PROCEED Ventral Patch is a sterile, self-expanding, partially absorbable, flexible mesh device that utilizes the proven design of PROCEED Surgical Mesh. The unique product design offers surgeons secure and stable deployment,(1) strength without ePTFE (expanded polytetrafluoroethylene),(2) and a macroporous / partially absorbable construction.(3) The PVP Device is available in small (4.3 cm) and medium (6.4 cm) sizes.

Dr. Carl Doerhoff, the first surgeon to implant the PVP Device in a human patient in the US, stated, "I'm very excited about the new technology advancements present in the PVP Device. Knowing that the product is flexible and partially absorbable for a greater likelihood of long-term patient comfort is an added benefit."

The PROCEED Ventral Patch is made by ETHICON, INC., a Johnson & Johnson company. ETHICON continues Johnson & Johnson's 100-year commitment to wound care today with innovative products for general surgery, wound management, women's health and urology, and wound closure. For more information about ETHICON visit www.ethicon.com.

(1) Data on file. ETHICON, INC.

(2) Welty G, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia. 2001;5(3):142-147.

(3) Harrell AG, Novitsky YW, Cristiano JA, et al. Prospective histologic evaluation of intra-abdominal prosthetics four months after implantation in a rabbit model. Surg Endosc. 2007;21:1170-1174.

    Contact:    Michelle Bauman
                (908) 218-2463
                ETHICON, Inc.
                mbauman@its.jnj.com


'/>"/>
SOURCE ETHICON, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ethicon Endo-Surgery Submits Application to FDA for Approval of the SEDASYS(TM) System - the First Computer-Assisted Personalized Sedation System
2. ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business
3. ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners
4. Board-Certified Bariatric Surgeon, Trace Curry, MD Places First Next-Generation Ethicon Endo-Surgery REALIZE™ Adjustable Gastric Band-C in Ohio
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. UPMC Health Plan Launches New Personal Health Record
7. HealthInsuranceFinders.com Launches Video Contest for Young Directors
8. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
9. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
10. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
11. Mannatech Launches Phase One of New Sales and Training Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: